StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 19M, up 20.8% from the year before. The highest annual figure on record is 19M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202519M+20.8%
FY2024Dec 31, 202415M+14.8%
FY2023Dec 31, 202313M-2.1%
FY2022Dec 31, 202214M+0.3%
FY2021Dec 31, 202114M+23.2%
FY2020Dec 31, 202011M–

More CASI Pharmaceuticals figures

See a number that looks wrong?